Management of oral leukoplakia with an 808-nm high-power diode laser: a single-center experience.

Abstract

High-power diode laser emerges as a promising approach to the treatment of oral leukoplakia (OL); however, its short- and long-term effects have been barely explored. This study evaluated the postoperative endpoints and the recurrence rate of high-power diode laser treatment in a well-defined series of patients with OL. A prospective analysis was performed on 22 individuals comprising 31 OL. The lesions were irradiated using the following protocol: Indium-Gallium-Arsenide diode laser, 808nm, continuous-wave mode, 1.5-2.0 W, 780.0 ± 225.1J, and 477.1 ± 131.8s. Postoperative pain was assessed with a visual analog scale at three endpoints. Clinical follow-up was performed on all patients and the Kaplan-Meier test was used to analyze the probability of recurrence. The series consisted mostly of women (72.7%) with a mean age of 62.8years. A single laser session was performed in 77.4% of cases. The median score on the scale that assessed pain on the 1st, 14th and 42nd postoperative day was 4, 1, and 0, respectively. The mean follow-up period per lesion was 28.6months (range: 2-53months). A complete response was observed in 93.5% of OL cases, while 6.5% had recurrence. The probability of recurrence at 39months was 6.7%. No patient experienced malignant transformation. High-power diode laser for the treatment of OL is safe and effective during the trans- and postoperative period. These findings represent an alternative approach to the management of OL, mainly because a low recurrence rate was observed.